Healthcare and drug development have recently been up-ended by a number of factors, most notably the ongoing pandemic, but also by an increasing focus on improved outcomes through value-based care.
With this shift comes opportunities to improve patient centricity from initial development to final healthcare delivery, whether the aim is to develop personalized medicine or improve equitable access to care through telemedicine and virtual clinical trials.
Biopharma companies unable to pivot within this rapidly evolving environment are likely to be left behind. However, the complexity of the health markets and vast amount of data create challenges in deciding the best path forward. Clarivate is here to help you achieve success, based on our long history of high-value, connected data, biopharma analytics and insights products and biopharma services that support rapid, evidence-based decisions.
Our biopharma solutions help advance innovation and accelerate patient-centric outcomes.
Pinpoint your ideal patient and address true patients’ needs through designing treatments with comprehensive scientific and clinical intelligence.
Optimize drug discovery and strategically translate your drug from the lab to the clinic by equipping your teams with the data they need and overcome the challenges of finding, integrating and analyzing key information. Free up your teams to focus on accelerating drug R&D and getting patients’ lifesaving therapies quicker.
Streamline cross-team collaboration and ensure compliance along the drug life cycle to increase your chances of positive regulatory and Health Technology Asessment (HTA) outcomes.
Enable all regulatory and compliance teams to easily track changing legislation and monitor drug safety risks with high-quality, comprehensive regulatory, pharmacovigilance and HTA intelligence. Overcome the challenges of identifying and monitoring the latest guidelines, adverse events, and HTA outcomes and empower your teams to focus on setting your therapies up for regulatory and HTA success.
Our industry experts, data scientists and epidemiologists help pharma teams make sense of the vast amount of available epidemiological, real-world patient and market data to understand the global and localized markets, from a high-level overview to the most granular niche patient segments.
With access to biopharma insights on M&A activity, challenging pricing and purchasing conditions, drug pipeline and customer dynamics, our experts help you understand the disease population and competitive landscape of interest for more accurate forecasting and greater confidence in planning commercial investments.
Strategically launch and position your product in the market for maximum patient benefit and transform your sales and account management strategies and skillsets in response to evolving customer dynamics and value drivers.
Our best-in-class data stack and robust methodologies provide insight into the constantly changing influences over care decisions, including clinical standards of care, system and payer affiliations, digital influence and more. When combined with our market expertise, your sales teams can effectively engage the right contacts and uncover sales opportunities not seen by other vendors.
The increasing decentralization of healthcare has highlighted the need to meet patients where they are and equip physicians with the knowledge and tools they need to optimize patient care and treatment adherence.
Our team’s comprehensive understanding of the healthcare customer experience enables healthcare brands to connect with customers regardless of geographic location, demographic characteristics and level of digital proficiency.
Clarivate offers proprietary market access data sets aggregated to provide a comprehensive view of today’s healthcare ecosystem and offer invaluable biopharma insights from pre-launch through product maturity.
Simplify your analysis by leveraging our global, yet locally specialized market access solutions. Our single source of integrated, customizable healthcare data provides invaluable biopharma insights into the global markets you need to understand most.
Unlock hyper-local and hyper-targeted assessments of patient populations, markets and treatment influencers to set pricing and contract strategies, account segmentation and guide you through the evolving complexities of the global reimbursement markets.
Our Research Intelligence Cloud makes it easier for you to collect, analyze and gain precise, actionable biopharma insights across the entire R&D lifecycle, meaning you can make critical decisions faster and with greater confidence.
Want to know more about the Research Intelligence Cloud?
“Working with the Clarivate team showed me the power of linking claims with EHR for sizing and understanding patient populations and the impact on your business decisions – that was a lightbulb moment for me. I really value that partnership of being able to call up my Clarivate specialist to brainstorm how to use this integrated data to tackle our most challenging questions.”
“When I prepare our executive team for a meeting with a potential partner, I say ‘Here are all the different companies and the various stages they are at,’ so they can understand that this company is working on this, and this company is taking this approach or that approach. The competitive data has to be very targeted. And these are things that are determined very easily using Clarivate.”